skin cancer

A single drug may control skin cancer treatment costsA $78 single course of topical fluorouracil for keratinocyte carcinoma and actinic keratosis lesions, could lead to a savings in the hundreds of dollars in follow-up costs.
How deep an SCC lies within the skin correlates to lesion lengthThis study, which may have direct implications for treatment, explains why some actinic keratoses recur and progress after superficial destructive treatments — like cryotherapy.
How deep an SCC lies within the skin correlates to lesion lengthThis study, which may have direct implications for treatment, explains why some actinic keratoses recur and progress after superficial destructive treatments — like cryotherapy.
Groundbreaking discovery may lead to new treatments for epithelial cancersNow, scientists know how one gene mutation leads to skin cancer — as well as other epithelial cancers such as lung, esophagus, mouth and throat. This groundbreaking discovering may lead to the development of new treatments and clinical trials.
Skin microbiome: More fragile, less diverse in urban areasThe decrease in the diversity of skin microbiome in megacities may contribute to a higher incidence of skin diseases in more urbanized environments, researchers report.
From new vaccines to the advent of new neurotoxinsPhysicians weigh in expectations for new developments within all facets of dermatology from pediatric dermatology to dermatopathology.
Managing hedgehog therapies for basal cell carcinomaWhile the vast majority of basal cell carcinomas are treated and resolved with surgery, systemic therapy with one of the two hedgehog pathway inhibitors could be a treatment option for unresectable or metastasized disease, researchers reported at the American Academy of Dermatology annual meeting in San Diego this week.
Multidisciplinary care improves patient outcomesMultidisciplinary skin cancer care is an approach that might not only improve patient outcomes, but also professional satisfaction, researchers reported at AAD 2018 this week in San Diego.
Revised tumor classification for head and neck CSCCAJCC updates classifications for head and neck cutaneous squamous cell carcinoma. AJCC 8 expands criteria for cases that now qualify to be T3. Now, T3 and T4 capture more poor outcomes.
Ruler is better than eye for pigment measurePhysicians should measure pigmented lesion diameter with a ruler rather than estimating via landmarks or the naked eye, a study shows.